<DOC>
	<DOCNO>NCT00639145</DOCNO>
	<brief_summary>The purpose study find antiretroviral drug safe well tolerate HIV-positive pregnant woman infant South Africa Zambia .</brief_summary>
	<brief_title>Elizabeth Glaser Pediatric AIDS Foundation Maternal Events Pregnancy Outcomes ( MEP Project ) A Multi-site Protocol</brief_title>
	<detailed_description>Although use HAART pregnancy significantly reduce rate vertical transmission HIV-1 , question remain regard safety therapy potential impact uninfected infant . The overall goal project establish voluntary exposure-registry perform observational surveillance HIV - positive pregnant woman expose antiretroviral product prenatal period , order evaluate outcome pregnancy safety product HIV-positive pregnant woman , infant .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>HIV Seropositivity</mesh_term>
	<criteria>HIV positive pregnant woman antiretroviral treatment Able willing participate provide inform consent Be least 18 year age old legal age provide consent If legal age , must legal guardian able give consent Be emancipate minor History mental illness History condition would preclude provision consent Inability provide consent</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>HIV</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Antiretrovirals</keyword>
	<keyword>HIV Seronegativity</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>